Correlates of Hypertension among Persons with HIV at Livingstone Central Hospital: CHAP study [post]

Sody Mweetwa Munsaka, Annet Kirabo, Benson M. Hamooya, Musalula Sinkala, John R. Koethe, Leta Pilic, Douglas C. Heimburger, Sepiso Kenias Masenga
2021 unpublished
Background: Persons with HIV (PWH) are more likely to develop hypertension and cardiovascular disease than the HIV-negative population. The new hypertension guidelines by the American Heart Association (AHA) and the American College of Cardiology (ACC) lowered the definition of hypertension from a systolic and diastolic blood pressure (BP) of ≥140/90mmHg to ≥130/80, respectively. This study was aimed at determining the prevalence and factors associated with hypertension in PWH using the new
more » ... rtension diagnostic criteria.Methods: This was a cross-sectional study. We recruited 226 antiretroviral treated PWH attending routine visits. Socio-demographic, health, and clinical data including BP readings were collected. Interviewer-structured questionnaires adapted from the World Health Organization Stepwise approach to Surveillance (WHO STEPs) and the international physical activity questionnaire (IPAQ) were used to collect data. Statistical evaluations were employed to elucidate relationships between hypertension and all response variables.Results: The prevalence of hypertension using the old and new guidelines was 16% and 42%, respectively. Factors significantly associated with increased and reduced odds for developing hypertension after adjustments in multivariate logistic regression were age, body mass index (BMI), employment status, fasting blood sugar (FBS) and table salt consumption, respectively (p<0.05 for all). Using the new AHA/ACC criteria for hypertension shifted the prevalence from 16% (old criteria) to 42%.Conclusion: The major risk factors associated with hypertension in PWH were increasing age, BMI and FBS. We recommend inclusion of FBS in routine measurements in PWH. The AHA/ACC new guidelines should be re-enforced in low-cost settings to increase the treatment of hypertension among PWH.
doi:10.21203/rs.3.rs-428625/v1 fatcat:3lfqz4zcybffxnhnnpterqccxm